Jon Cuthbert

The U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental Biologics License Application (sBLA) for DATROWAY® (datopotamab deruxtecan), a TROP2-directed antibody-drug conjugate (ADC).

Arizona Attorney General Kris Mayes has issued a warning over rising crypto ATM scams and launched a new fraud reporting tool as losses mount, particularly among older adults.

Cboe Global Markets is in early talks to relaunch “all-or-nothing” binary options for retail investors, targeting the fast-growing prediction market sector, according to a Wall Street Journal report.

Kevin Warsh, President Donald Trump’s nominee to chair the Federal Reserve, previously advised Anchorage Digital, a key partner in Tether’s push to launch a US-regulated stablecoin.

Jupiter has secured a $35 million strategic investment into its $JUP token from ParaFi Capital, revealed during its CatLumpurr community conference in Kuala Lumpur.

Crypto firms and banks failed to reach a compromise on stablecoin yields at a White House meeting as negotiations continue over a Senate bill to regulate US crypto market structure.

Ryman Healthcare (ASX:RYM), the trans-Tasman leader in retirement living, announced a sweeping strategic overhaul and a new capital management framework aimed at unlocking value from its $12 billion portfolio.

The Federal Court of Australia has approved the acquisition of RPMGlobal (ASX:RUL) by Caterpillar through its subsidiary, Revolution HoldCo.

NRW Holdings (ASX:NWH) has kicked off 2026 with a significant expansion of its order book, securing three major civil infrastructure contracts across Western Australia.

Debt ledger specialist Credit Corp (ASX:CCP) reaffirmed its FY26 outlook, projecting a net profit growth of 6% to 17% following a steady first-half performance.